Second, we acknowledge that further studies should be performed to fine map the genetic variations within RPA1 gene locus and explore their regulatory potentials on RPA1 expression, as well as the exact role of RPA1 as a potential target of radiosensitizer for treatment of NPC. Here, RPA1 is linked to nasopharyngeal carcinoma.